Two patients with concomitant bullous pemphigoid and psoriasis successfully treated by IL-23 inhibition

被引:2
|
作者
Cole, Connor [1 ,4 ]
Amber, Kyle T. [2 ,3 ]
机构
[1] Rush Med Coll, Chicago, IL USA
[2] Rush Univ, Dept Dermatol, Med Ctr, Chicago, IL USA
[3] Rush Univ, Dept Internal Med, Med Ctr, Chicago, IL USA
[4] Rush Med Coll, 1826 Erie St APT BF, Chicago, IL 60622 USA
关键词
USTEKINUMAB;
D O I
10.1111/jdv.19317
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:E1339 / E1340
页数:2
相关论文
共 50 条
  • [31] A case of infantile bullous pemphigoid successfully treated with compound glycyrrhizin tablets
    Xu, Kejia
    Wei, Yi
    Wang, Tingting
    Ding, Li
    Li, Wei
    Wang, Lin
    DERMATOLOGIC THERAPY, 2020, 33 (04)
  • [32] SEVERE REFRACTORY BULLOUS PEMPHIGOID IN A PEDIATRIC PATIENT SUCCESSFULLY TREATED WITH IMMUNOADSORPTION
    Victor, Perez-beltran
    Anna, Pujol-manresa
    Marina, Munoz
    Laura, Seidler-nussenbaum
    Mireia, Lopez-corbeto
    Vicenc, Garcia-Patos
    Gema, Ariceta
    PEDIATRIC NEPHROLOGY, 2021, 36 (10) : 3426 - 3426
  • [33] Refractory bullous pemphigoid with prurigo nodularis successfully treated with dupilumab monotherapy
    Lai, Po-Ta
    Tseng, Han-Chi
    DERMATOLOGICA SINICA, 2022, 40 (04) : 237 - 238
  • [34] REFRACTORY BULLOUS PEMPHIGOID LEADING TO RESPIRATORY ARREST AND SUCCESSFULLY TREATED WITH PLASMAPHERESIS
    KONSTADT, JW
    REMLINGER, K
    SCHILD, J
    ARONSON, I
    BENNIN, B
    SOLOMON, L
    ARCHIVES OF DERMATOLOGY, 1990, 126 (09) : 1241 - 1242
  • [35] IL-23/IL-17 Axis Activates IL-1β-Associated Inflammasome in Macrophages and Generates an Auto-Inflammatory Response in a Subgroup of Patients With Bullous Pemphigoid
    Le Jan, Sebastien
    Muller, Celine
    Plee, Julie
    Durlach, Anne
    Bernard, Philippe
    Antonicelli, Frank
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [36] Concurrent bullous pemphigoid and psoriasis vulgaris successfully treated with Janus kinase inhibitor tofacitinib: A case report and review of the literature
    Li, Hongda
    Wang, Honglei
    Qiao, Guizhi
    Liu, Yongxia
    Zhang, Furen
    Pan, Futang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 122
  • [37] IL-23 inhibitors for moderate-to-severe psoriasis
    Ibler, Erin
    Gordon, Kenneth B.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2018, 37 (03) : 158 - 162
  • [38] Advancements in Biologic Therapy for Psoriasis: the IL-23 Inhibitors
    Hadeler, Edward
    Mosca, Megan
    Hong, Julie
    Brownstone, Nicholas
    Bhutani, Tina
    Liao, Wilson
    CURRENT DERMATOLOGY REPORTS, 2021, 10 (01) : 6 - 15
  • [39] Advancements in Biologic Therapy for Psoriasis: the IL-23 Inhibitors
    Edward Hadeler
    Megan Mosca
    Julie Hong
    Nicholas Brownstone
    Tina Bhutani
    Wilson Liao
    Current Dermatology Reports, 2021, 10 : 6 - 15
  • [40] Tildrakizumab (Ilumya) - Another IL-23 Antagonist for Psoriasis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1563): : 4 - 6